{"longTitle":"TCGA uterine carcinosarcoma (UCS) gene-level nonsilent somatic mutation (bcm automated)","cohort":"TCGA Uterine Carcinosarcoma (UCS)","url":"https://tcga-data.nci.nih.gov/tcgafiles/ftp_auth/distro_ftpusers/anonymous/tumor/ucs/gsc/hgsc.bcm.edu/illuminaga_dnaseq_automated/mutations/","probeMap":"probeMap/hugo_gencode_good_hg19_V24lift37_probemap","dataSubType":"somatic non-silent mutation (gene-level)","security":"public","label":"bcm automated","method":"Baylor pipeline","tags":["cancer"],"path":"data/public/TCGA/UCS/mutation_bcm_gene","anatomical_origin":["Uterus"],"name":"TCGA.UCS.sampleMap/mutation_bcm_gene","dataproducer":"Baylor College of Medicine Human Genome Sequencing Center","wrangling_procedure":"Download .maf file from TCGA DCC, processed into gene by sample matrix at UCSC, stored in the UCSC Xena repository","sample_type":["tumor"],"redistribution":true,"type":"genomicMatrix","wrangler":"xena TCGAscript maf processed on 2018-01-12","version":"2018-01-12","gdata_tags":["Baylor College of Medicine Human Genome Sequencing Center"],"unit":"binary non-silent mutation","primary_disease":"uterine carcinosarcoma","platform":"IlluminaGA","description":"TCGA uterine carcinosarcoma (UCS) somatic mutation data.  Sequencing data are generated on a IlluminaGA system. The calls are generated at Baylor College of Medicine Human Genome Sequencing Center using the Baylor pipeline method. <br><br> Red (=1) indicates that a non-silent somatic mutation (nonsense, missense, frame-shif indels, splice site mutations, stop codon readthroughs, change of start codon, inframe indels) was identified in the protein coding region of a gene, or any mutation identified in a non-coding gene. White (=0) indicates that none of the above mutation calls were made in this gene for the specific sample.<br><br>"}

TCGA uterine carcinosarcoma (UCS) gene-level nonsilent somatic mutation (bcm automated)

TCGA uterine carcinosarcoma (UCS) DNA methylation (HumanMethylation450)

{"longTitle":"TCGA uterine carcinosarcoma (UCS) copy number gistic2 estimate","cohort":"TCGA Uterine Carcinosarcoma (UCS)","url":"http://gdac.broadinstitute.org/runs/analyses__2016_01_28/data/UCS/20160128/","dataSubType":"copy number (gene-level)","security":"public","label":"gistic2","tags":["cancer"],"path":"data/public/TCGA/UCS/Gistic2_CopyNumber_Gistic2_all_data_by_genes","anatomical_origin":["Uterus"],"name":"TCGA.UCS.sampleMap/Gistic2_CopyNumber_Gistic2_all_data_by_genes","dataproducer":"TCGA FIREHOSE pipeline","wrangling_procedure":"FIREHOSE data download from TCGA DCC, processed at UCSC into xena repository","sample_type":["tumor"],"redistribution":true,"groupTitle":"TCGA uterine carcinosarcoma","type":"genomicMatrix","wrangler":"xena TCGAscript CopyNumber_Gistic2 processed on 2017-09-08","version":"2017-09-08","unit":"Gistic2 copy number","primary_disease":"uterine carcinosarcoma","description":"TCGA uterine carcinosarcoma (UCS) gene-level copy number variation (CNV) estimated using the GISTIC2 method.<br><br> Copy number profile was measured experimentally using whole genome microarray at a TCGA genome characterization center. Subsequently, TCGA FIREHOSE pipeline applied GISTIC2 method to produce segmented CNV data, which was then mapped to genes to produce gene-level estimates. Genes are mapped onto the human genome coordinates using UCSC xena HUGO probeMap. Reference to GISTIC2 method PMID:21527027.<br><br>"}